Endocrinology

Back to articles

Obesity in children alters drug exposure, pharmacokinetics

September 29, 2015
  • Advising on this article:
  • Frank Pucino

KEY POINT

A systematic review of 20 studies revealed clinically significant pharmacokinetic alterations in children compared with control participants who were not obese for more than one-half of the drugs studied, with meaningful differences in drug exposure seen in approximately 40% of drugs studied.

SOURCES

Harskamp-van Ginkel MW et al. Drug dosing and pharmacokinetics in children with obesity: a systematic review. JAMA Pediatr. 2015;169:678–85.

Gillman MW et al. Children with obesity: how are they different [Editorial]? JAMA Pediatr. 2015;169:626–8. 

Recent Articles

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

More info

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.